PAUL STEVEN M

Insider Buys Quantity –
3
2022-04-01SaleAlnylam Pharmaceuticals, Inc.
ALNY
90
<0.0001%
$174.33$15,690+18.01%
2020-12-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
15,000
0.0128%
$140.00$2.1M+19.4%
2020-02-10SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0263%
$130.00$3.9M+3.18%
2019-03-21SaleSage Therapeutics, Inc.
SAGE
director
7,879
0.0166%
$161.04$1.27M-1.3%
2019-03-20SaleSage Therapeutics, Inc.
SAGE
director
56,646
0.1236%
$161.29$9.14M+2.63%
2019-03-18SaleSage Therapeutics, Inc.
SAGE
director
3,775
0.008%
$161.05$607,977-0.26%
2019-03-01SaleSage Therapeutics, Inc.
SAGE
director
2,600
0.0054%
$161.00$418,600-0.73%
2019-02-25SaleSage Therapeutics, Inc.
SAGE
director
2,000
0.0042%
$161.00$322,000-0.58%
2019-02-19SaleSage Therapeutics, Inc.
SAGE
director
3,086
0.0067%
$161.62$498,746+3.78%
2019-02-15SaleSage Therapeutics, Inc.
SAGE
director
98,922
0.2041%
$161.02$15.93M-1.35%
2018-03-06SaleSage Therapeutics, Inc.
SAGE
director
116,278
0.2583%
$172.00$20M-15.13%
2016-01-14PurchaseVoyager Therapeutics, Inc.
VYGR
President and CEO
20,000
0.0801%
$14.07$281,380-11.93%
2015-09-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0703%
$52.41$1.05M-26.7%
2015-08-03SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0689%
$67.08$1.34M-38.19%
2015-07-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0697%
$69.40$1.39M-38.19%
2015-06-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0734%
$72.34$1.45M-35%
2015-05-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.07%
$53.31$1.07M-5.95%
2015-04-01SaleSage Therapeutics, Inc.
SAGE
director
20,000
0.0685%
$48.51$970,200+4.25%
2015-01-26PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
2,000
0.0024%
$95.00$190,000+10.43%
2014-07-23PurchaseSage Therapeutics, Inc.
SAGE
director
10,000
0.0334%
$18.00$180,000+46.89%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us